As December 2025 closes, Omicron subvariants XFV, NW.1, and LF.7 are gaining traction, comprising up to 20% of cases in key regions. This nowcast analyzes their rise, mutation profiles, and influence on 2026 COVID vaccine formulations, with CDC and WHO data guiding preparedness.
Read More